WO1995001764A3 - Ocular insert with anchoring protrusions - Google Patents
Ocular insert with anchoring protrusions Download PDFInfo
- Publication number
- WO1995001764A3 WO1995001764A3 PCT/US1994/007136 US9407136W WO9501764A3 WO 1995001764 A3 WO1995001764 A3 WO 1995001764A3 US 9407136 W US9407136 W US 9407136W WO 9501764 A3 WO9501764 A3 WO 9501764A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ocular insert
- length
- protrusions
- anchoring protrusions
- circular
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002165071A CA2165071C (en) | 1993-06-29 | 1994-06-20 | Ocular insert with anchoring protrusions |
EP94923238A EP0707464A4 (en) | 1993-06-29 | 1994-06-20 | Ocular insert with anchoring protrusions |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/083,303 | 1993-06-29 | ||
US08/083,303 US5322691A (en) | 1986-10-02 | 1993-06-29 | Ocular insert with anchoring protrusions |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1995001764A2 WO1995001764A2 (en) | 1995-01-19 |
WO1995001764A3 true WO1995001764A3 (en) | 1995-03-02 |
Family
ID=22177459
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1994/007136 WO1995001764A2 (en) | 1993-06-29 | 1994-06-20 | Ocular insert with anchoring protrusions |
Country Status (5)
Country | Link |
---|---|
US (2) | US5322691A (en) |
EP (1) | EP0707464A4 (en) |
JP (1) | JP2995137B2 (en) |
CA (1) | CA2165071C (en) |
WO (1) | WO1995001764A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8691265B2 (en) | 2006-03-31 | 2014-04-08 | Mati Therapeutics, Inc. | Drug delivery methods, structures, and compositions for nasolacrimal system |
Families Citing this family (134)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5989579A (en) * | 1986-10-02 | 1999-11-23 | Escalon Medical Corp. | Ocular insert with anchoring protrusions |
US5322691A (en) * | 1986-10-02 | 1994-06-21 | Sohrab Darougar | Ocular insert with anchoring protrusions |
US5817075A (en) * | 1989-08-14 | 1998-10-06 | Photogenesis, Inc. | Method for preparation and transplantation of planar implants and surgical instrument therefor |
SG49267A1 (en) | 1989-08-14 | 1998-05-18 | Photogenesis Inc | Surgical instrument and cell isolation and transplantation |
US6514238B1 (en) * | 1989-08-14 | 2003-02-04 | Photogenesis, Inc. | Method for preparation and transplantation of volute grafts and surgical instrument therefor |
US6045791A (en) * | 1992-03-06 | 2000-04-04 | Photogenesis, Inc. | Retinal pigment epithelium transplantation |
JP3720386B2 (en) * | 1993-12-27 | 2005-11-24 | 住友製薬株式会社 | Drug release controlled formulation |
US5618274A (en) * | 1994-04-08 | 1997-04-08 | Rosenthal; Kenneth J. | Method and device for deep pressurized topical, fornix applied "nerve block" anesthesia |
US5868728A (en) * | 1995-02-28 | 1999-02-09 | Photogenesis, Inc. | Medical linear actuator for surgical delivery, manipulation, and extraction |
US5869079A (en) * | 1995-06-02 | 1999-02-09 | Oculex Pharmaceuticals, Inc. | Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
US20060280774A1 (en) * | 1995-06-02 | 2006-12-14 | Allergan, Inc. | Compositions and methods for treating glaucoma |
US6299895B1 (en) | 1997-03-24 | 2001-10-09 | Neurotech S.A. | Device and method for treating ophthalmic diseases |
DK0973499T3 (en) * | 1997-03-31 | 2003-11-17 | Alza Corp | Implantable diffusion delivery system |
US6196993B1 (en) * | 1998-04-20 | 2001-03-06 | Eyelab Group, Llc | Ophthalmic insert and method for sustained release of medication to the eye |
CA2358296A1 (en) * | 1999-01-05 | 2000-07-13 | Anthony P. Adamis | Targeted transscleral controlled release drug delivery to the retina and choroid |
CA2383572C (en) | 1999-10-21 | 2007-12-11 | Alcon Universal Ltd. | Sub-tenon drug delivery |
US7943162B2 (en) * | 1999-10-21 | 2011-05-17 | Alcon, Inc. | Drug delivery device |
US6416777B1 (en) * | 1999-10-21 | 2002-07-09 | Alcon Universal Ltd. | Ophthalmic drug delivery device |
ATE283013T1 (en) | 1999-10-21 | 2004-12-15 | Alcon Inc | MEDICATION DELIVERY DEVICE |
US6264971B1 (en) | 1999-11-04 | 2001-07-24 | Btg International Limited | Ocular insert |
US6726918B1 (en) | 2000-07-05 | 2004-04-27 | Oculex Pharmaceuticals, Inc. | Methods for treating inflammation-mediated conditions of the eye |
ATE547080T1 (en) * | 2000-08-30 | 2012-03-15 | Univ Johns Hopkins | DEVICES FOR INTRAOCULAR DRUG DELIVERY |
ES2250504T3 (en) | 2000-11-29 | 2006-04-16 | Allergan Inc. | PREVENTION OF REJECTION OF GRAFT IN THE EYE. |
US6713081B2 (en) * | 2001-03-15 | 2004-03-30 | The United States Of America As Represented By The Department Of Health And Human Services | Ocular therapeutic agent delivery devices and methods for making and using such devices |
JP2004536631A (en) | 2001-05-03 | 2004-12-09 | マサチューセッツ・アイ・アンド・イア・インファーマリー | Implantable drug delivery device and use thereof |
EP1404297B1 (en) | 2001-06-12 | 2011-04-27 | The Johns Hopkins University School Of Medicine | Reservoir device for intraocular drug delivery |
AU2002319606B2 (en) * | 2001-07-23 | 2006-09-14 | Alcon, Inc. | Ophthalmic drug delivery device |
EP1409065B1 (en) | 2001-07-23 | 2007-01-17 | Alcon, Inc. | Ophthalmic drug delivery device |
WO2003015667A1 (en) * | 2001-08-03 | 2003-02-27 | David Castillejos | Method and intra sclera implant for treatment of glaucoma and presbyopia |
WO2003068053A2 (en) * | 2002-02-14 | 2003-08-21 | Photogenesis, Inc. | Subretinal implantation device and surgical cannulas for use therewith |
AU2003217531A1 (en) * | 2002-05-02 | 2003-11-17 | Massachusetts Eye And Ear Infirmary | Ocular drug delivery systems and use thereof |
JP5583310B2 (en) * | 2002-12-20 | 2014-09-03 | チャクシュ・リサーチ・インコーポレーテッド | Ophthalmic formulation for prevention and treatment of ocular symptoms |
US20050048099A1 (en) * | 2003-01-09 | 2005-03-03 | Allergan, Inc. | Ocular implant made by a double extrusion process |
WO2004073551A2 (en) * | 2003-02-18 | 2004-09-02 | Massachusetts Eye And Ear Infirmary | Transscleral drug delivery device and related methods |
CA2524271C (en) * | 2003-05-02 | 2012-09-04 | Surmodics, Inc. | Controlled release bioactive agent delivery device |
US8246974B2 (en) * | 2003-05-02 | 2012-08-21 | Surmodics, Inc. | Medical devices and methods for producing the same |
ZA200508654B (en) * | 2003-07-10 | 2007-01-31 | Alcon Inc | Ophthalmic drug delivery device |
JP4869930B2 (en) * | 2003-08-26 | 2012-02-08 | ヴィスタ サイエンティフィック エルエルシー | Ophthalmic drug supply device |
ES2388138T3 (en) * | 2003-08-27 | 2012-10-09 | Ophthotech Corporation | Combination therapy for the treatment of ocular neovascular disorders |
AU2004274026A1 (en) * | 2003-09-18 | 2005-03-31 | Macusight, Inc. | Transscleral delivery |
US20050232972A1 (en) * | 2004-04-15 | 2005-10-20 | Steven Odrich | Drug delivery via punctal plug |
US20050244469A1 (en) | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Extended therapeutic effect ocular implant treatments |
US20060024350A1 (en) * | 2004-06-24 | 2006-02-02 | Varner Signe E | Biodegradable ocular devices, methods and systems |
AU2005269988B2 (en) | 2004-07-02 | 2012-02-02 | Mati Therapeutics Inc. | Treatment medium delivery device and methods for delivery |
US20060110428A1 (en) * | 2004-07-02 | 2006-05-25 | Eugene Dejuan | Methods and devices for the treatment of ocular conditions |
AU2005325213B2 (en) | 2004-08-04 | 2010-10-07 | Evonik Corporation | Methods for manufacturing delivery devices and devices thereof |
US7722669B2 (en) * | 2004-08-13 | 2010-05-25 | Richard Foulkes | Method and insert for modifying eye color |
KR20070101865A (en) * | 2004-12-22 | 2007-10-17 | 알콘, 인코퍼레이티드 | Device for ophthalmic drug delivery |
US8663639B2 (en) * | 2005-02-09 | 2014-03-04 | Santen Pharmaceutical Co., Ltd. | Formulations for treating ocular diseases and conditions |
KR101387456B1 (en) | 2005-02-09 | 2014-04-21 | 산텐 세이야꾸 가부시키가이샤 | Liquid formulations for treatment of diseases or conditions |
WO2006110487A1 (en) * | 2005-04-08 | 2006-10-19 | Surmodics, Inc. | Sustained release implants for subretinal delivery |
CN101600475A (en) | 2005-07-27 | 2009-12-09 | 佛罗里达大学研究基金会有限公司 | Revise the miniaturization compound and the use thereof of protein false folding |
US8067189B2 (en) * | 2005-09-01 | 2011-11-29 | Bristol-Myers Squibb Company | Methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators by measuring the level of collagen type IV |
MX2008006379A (en) | 2005-11-29 | 2009-03-03 | Smithkline Beecham Corp | Treatment method. |
US20070178138A1 (en) * | 2006-02-01 | 2007-08-02 | Allergan, Inc. | Biodegradable non-opthalmic implants and related methods |
EP2001438A2 (en) | 2006-02-09 | 2008-12-17 | Macusight, Inc. | Stable formulations, and methods of their preparation and use |
DK2001466T3 (en) | 2006-03-23 | 2016-02-29 | Santen Pharmaceutical Co Ltd | LOW-DOSAGE RAPAMYCINE FOR TREATMENT OF VASCULAR PERMEABILITY-RELATED DISEASES |
US20070298073A1 (en) * | 2006-06-23 | 2007-12-27 | Allergan, Inc. | Steroid-containing sustained release intraocular implants and related methods |
US8802128B2 (en) * | 2006-06-23 | 2014-08-12 | Allergan, Inc. | Steroid-containing sustained release intraocular implants and related methods |
US8394488B2 (en) * | 2006-10-06 | 2013-03-12 | Cordis Corporation | Bioabsorbable device having composite structure for accelerating degradation |
US8828419B2 (en) * | 2006-10-06 | 2014-09-09 | Cordis Corporation | Bioabsorbable device having encapsulated additives for accelerating degradation |
JP2010514517A (en) * | 2006-12-26 | 2010-05-06 | キューエルティー プラグ デリバリー,インク. | Drug delivery implants for the suppression of visual defects |
US20080265343A1 (en) * | 2007-04-26 | 2008-10-30 | International Business Machines Corporation | Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof |
KR101996336B1 (en) * | 2007-09-07 | 2019-07-04 | 마티 테라퓨틱스 인코포레이티드 | Drug cores for sustained release of therapeutic agents |
EP2205192A2 (en) * | 2007-09-07 | 2010-07-14 | QLT Plug Delivery, Inc. | Insertion and extraction tools for lacrimal implants |
CA2698508C (en) | 2007-09-07 | 2017-06-06 | Alan R. Rapacki | Lacrimal implants and related methods |
CA2698580C (en) | 2007-09-07 | 2016-10-11 | Qlt Plug Delivery, Inc. | Lacrimal implant detection |
TWI498136B (en) * | 2007-10-09 | 2015-09-01 | Alcon Res Ltd | An injection device for delivering a rate and temperature-dependent substance into the eye and method of preparing the same |
TWI451862B (en) * | 2007-10-09 | 2014-09-11 | Alcon Res Ltd | Thermal coefficient driven drug pellet size for ophthalmic injection |
ES2718612T3 (en) | 2007-12-20 | 2019-07-03 | Evonik Corp | Procedure for preparing microparticles that have a low volume of residual solvent |
CN102014816B (en) * | 2008-02-18 | 2015-04-15 | 马缇医疗股份有限公司 | Lacrimal implants and related methods |
CA2722002C (en) | 2008-04-30 | 2018-06-19 | Qlt Plug Delivery, Inc. | Composite lacrimal insert and related methods |
CN105251007A (en) * | 2008-05-09 | 2016-01-20 | 马缇医疗股份有限公司 | Sustained release delivery of active agents to treat glaucoma and ocular hypertension |
WO2010062394A2 (en) * | 2008-11-26 | 2010-06-03 | Surmodics, Inc. | Implantable ocular drug delivery device and methods |
PL2391419T3 (en) | 2009-01-29 | 2019-12-31 | Forsight Vision4, Inc. | Posterior segment drug delivery |
US8623395B2 (en) | 2010-01-29 | 2014-01-07 | Forsight Vision4, Inc. | Implantable therapeutic device |
CN105997339B (en) * | 2009-02-23 | 2018-09-04 | 马缇医疗股份有限公司 | Lacrimal implants |
US20100226962A1 (en) * | 2009-03-03 | 2010-09-09 | Rodstrom Theron R | Peri-corneal drug delivery device |
US8372036B2 (en) | 2009-05-06 | 2013-02-12 | Alcon Research, Ltd. | Multi-layer heat assembly for a drug delivery device |
WO2010135369A1 (en) * | 2009-05-18 | 2010-11-25 | Dose Medical Corporation | Drug eluting ocular implant |
ES2921527T3 (en) | 2009-06-03 | 2022-08-29 | Forsight Vision5 Inc | Anterior segment drug delivery |
IN2012DN00352A (en) | 2009-06-16 | 2015-08-21 | Bikam Pharmaceuticals Inc | |
BR112012006443A2 (en) * | 2009-09-22 | 2017-07-25 | Evonik Degussa Corp | implant devices that feature variable loading configurations of bioactive agents |
US20120232102A1 (en) | 2009-09-30 | 2012-09-13 | Chun-Fang Xu | Methods Of Administration And Treatment |
CA2776748A1 (en) * | 2009-10-08 | 2011-04-14 | Neurotech Usa, Inc. | Use of pedf in an encapsulated cell-based delivery system |
US8177747B2 (en) | 2009-12-22 | 2012-05-15 | Alcon Research, Ltd. | Method and apparatus for drug delivery |
US8469934B2 (en) * | 2010-01-27 | 2013-06-25 | Alcon Research, Ltd. | Pulsatile peri-corneal drug delivery device |
US10166142B2 (en) | 2010-01-29 | 2019-01-01 | Forsight Vision4, Inc. | Small molecule delivery with implantable therapeutic device |
EP3861969A1 (en) | 2010-08-05 | 2021-08-11 | ForSight Vision4, Inc. | Injector apparatus for drug delivery |
SI2600812T1 (en) | 2010-08-05 | 2021-12-31 | ForSight Vision4, Inc., | Apparatus to treat an eye |
WO2012019139A1 (en) | 2010-08-05 | 2012-02-09 | Forsight Vision4, Inc. | Combined drug delivery methods and apparatus |
US8961501B2 (en) | 2010-09-17 | 2015-02-24 | Incept, Llc | Method for applying flowable hydrogels to a cornea |
CA2818612C (en) | 2010-11-19 | 2020-12-29 | Forsight Vision4, Inc. | Therapeutic agent formulations for implanted devices |
US20120157938A1 (en) * | 2010-12-16 | 2012-06-21 | Tokarski Jason M | Punctal plug with drug core retention features |
EA032666B1 (en) | 2011-06-14 | 2019-06-28 | Бикам Фармасьютикалз, Инк. | Opsin-binding ligands and methods of use thereof |
EP4249059A3 (en) | 2011-06-28 | 2023-11-29 | ForSight Vision4, Inc. | An apparatus for collecting a sample of fluid from a reservoir chamber of a therapeutic device for the eye |
CA2846384C (en) | 2011-08-29 | 2020-12-15 | Qlt Inc. | Sustained release delivery of active agents to treat glaucoma and ocular hypertension |
US9974685B2 (en) | 2011-08-29 | 2018-05-22 | Mati Therapeutics | Drug delivery system and methods of treating open angle glaucoma and ocular hypertension |
WO2013040238A2 (en) | 2011-09-13 | 2013-03-21 | Vista Scientific Llc | Sustained release ocular drug delivery devices and methods of manufacture |
RU2740680C2 (en) | 2011-09-14 | 2021-01-19 | Форсайт Вижн5, Инк. | Eye inserter device and methods |
SI2755600T1 (en) | 2011-09-16 | 2021-08-31 | Forsight Vision4, Inc. | Fluid exchange apparatus |
US10226417B2 (en) | 2011-09-16 | 2019-03-12 | Peter Jarrett | Drug delivery systems and applications |
EP2768307B1 (en) | 2011-10-19 | 2020-03-18 | Bikam Pharmaceuticals, Inc. | Opsin-binding ligands, compositions and methods of use |
US9353063B2 (en) | 2011-11-30 | 2016-05-31 | Bikam Pharmaceuticals, Inc. | Opsin-binding ligands, compositions and methods of use |
CA2862746A1 (en) | 2011-12-01 | 2013-06-06 | Bikam Pharmaceuticals, Inc. | Opsin-binding ligands, compositions and methods of use |
US9205150B2 (en) | 2011-12-05 | 2015-12-08 | Incept, Llc | Medical organogel processes and compositions |
US10010448B2 (en) | 2012-02-03 | 2018-07-03 | Forsight Vision4, Inc. | Insertion and removal methods and apparatus for therapeutic devices |
US9827401B2 (en) | 2012-06-01 | 2017-11-28 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
MX351261B (en) | 2012-06-01 | 2017-10-06 | Surmodics Inc | Apparatus and method for coating balloon catheters. |
PT2911623T (en) | 2012-10-26 | 2019-11-21 | Forsight Vision5 Inc | Ophthalmic system for sustained release of drug to eye |
US9745558B2 (en) | 2013-02-18 | 2017-08-29 | Vegenics Pty Limited | VEGFR-3 ligand binding molecules and uses thereof |
AU2014236455B2 (en) | 2013-03-14 | 2018-07-12 | Forsight Vision4, Inc. | Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant |
EP4302736A3 (en) | 2013-03-28 | 2024-04-03 | ForSight Vision4, Inc. | Ophthalmic implant for delivering therapeutic substances |
US10098836B2 (en) | 2013-05-02 | 2018-10-16 | Retina Foundation Of The Southwest | Method for forming a molded two-layer ocular implant |
CN105431204A (en) | 2013-07-12 | 2016-03-23 | 奥普索特克公司 | Methods for treating or preventing ophthalmological conditions |
US10258503B2 (en) | 2014-07-15 | 2019-04-16 | Forsight Vision4, Inc. | Ocular implant delivery device and method |
MY182793A (en) | 2014-08-08 | 2021-02-05 | Forsight Vision4 Inc | Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof |
JP5643460B1 (en) * | 2014-08-28 | 2014-12-17 | 株式会社ユニバーサルビュー | Eyelid interior tools |
WO2016031093A1 (en) * | 2014-08-28 | 2016-03-03 | 株式会社ユニバーサルビュー | Ocular insert device |
JP5671183B1 (en) * | 2014-08-28 | 2015-02-18 | 株式会社ユニバーサルビュー | Eyelid interior tools |
JP5643461B1 (en) * | 2014-08-28 | 2014-12-17 | 株式会社ユニバーサルビュー | Eyelid interior tools |
US10500091B2 (en) | 2014-11-10 | 2019-12-10 | Forsight Vision4, Inc. | Expandable drug delivery devices and methods of use |
EP3283004A4 (en) | 2015-04-13 | 2018-12-05 | Forsight Vision5, Inc. | Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent |
WO2016187426A1 (en) | 2015-05-19 | 2016-11-24 | Amorphex Therapeutics Llc | A device that delivers a sustained low-dose of a myopia-suppressing drug |
CN108430405B (en) | 2015-11-20 | 2021-04-13 | 弗赛特影像4股份有限公司 | Porous structures for sustained release drug delivery devices |
US11617680B2 (en) | 2016-04-05 | 2023-04-04 | Forsight Vision4, Inc. | Implantable ocular drug delivery devices |
US10383764B2 (en) * | 2016-10-31 | 2019-08-20 | Ebrahim Elahi | Eyelid implant device |
WO2019103906A1 (en) | 2017-11-21 | 2019-05-31 | Forsight Vision4, Inc. | Fluid exchange apparatus for expandable port delivery system and methods of use |
US20200268554A1 (en) * | 2018-05-12 | 2020-08-27 | Goldenbiotech, Llc | Self-Retaining Implantable Drug Delivery Device |
WO2020112816A1 (en) | 2018-11-29 | 2020-06-04 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
US11819590B2 (en) | 2019-05-13 | 2023-11-21 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
US20210169690A1 (en) * | 2019-12-10 | 2021-06-10 | Goldenbiotech, Llc | Self-Retaining Implantable Drug Delivery Device |
CA3220272A1 (en) * | 2021-05-14 | 2022-11-17 | Glaukos Corporation | Materials and methods for punctal plugs |
WO2023073706A1 (en) * | 2021-10-27 | 2023-05-04 | Avisi Ltd. | Ophthalmic device |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3828777A (en) * | 1971-11-08 | 1974-08-13 | Alza Corp | Microporous ocular device |
US4730013A (en) * | 1981-10-08 | 1988-03-08 | Merck & Co., Inc. | Biosoluble ocular insert |
US5229128A (en) * | 1986-06-11 | 1993-07-20 | Haddad Heskel M | Drug delivery ophthalmic insert and method of preparing same |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3995635A (en) * | 1971-09-09 | 1976-12-07 | Alza Corporation | Ocular insert |
US3949750A (en) * | 1974-10-07 | 1976-04-13 | Freeman Jerre M | Punctum plug and method for treating keratoconjunctivitis sicca (dry eye) and other ophthalmic aliments using same |
US4096238A (en) * | 1974-12-23 | 1978-06-20 | Alza Corporation | Method for administering drug to the gastrointestinal tract |
US4014335A (en) * | 1975-04-21 | 1977-03-29 | Alza Corporation | Ocular drug delivery device |
NL188266C (en) * | 1975-07-29 | 1992-05-18 | Merck & Co Inc | PROCESS FOR THE PREPARATION OF AN ORGANIC IMPLANT. |
US4034758A (en) * | 1975-09-08 | 1977-07-12 | Alza Corporation | Osmotic therapeutic system for administering medicament |
US4164559A (en) * | 1977-09-21 | 1979-08-14 | Cornell Research Foundation, Inc. | Collagen drug delivery device |
US5248700A (en) * | 1982-05-14 | 1993-09-28 | Akzo Nv | Active agent containing solid structures for prolonged release of active agents |
US4524776A (en) * | 1983-10-27 | 1985-06-25 | Withers Stanley J | Split carrier for eyelid sensor and the like |
GB8623661D0 (en) * | 1986-10-02 | 1986-11-05 | Darougar S | Ocular insert |
US5322691A (en) * | 1986-10-02 | 1994-06-21 | Sohrab Darougar | Ocular insert with anchoring protrusions |
US5147647A (en) * | 1986-10-02 | 1992-09-15 | Sohrab Darougar | Ocular insert for the fornix |
US5137728A (en) * | 1988-03-01 | 1992-08-11 | Bausch & Lomb Incorporated | Ophthalmic article |
US4975280A (en) * | 1989-01-23 | 1990-12-04 | Ethyl Corporation | Bioerodable sustained release implants |
US5164188A (en) * | 1989-11-22 | 1992-11-17 | Visionex, Inc. | Biodegradable ocular implants |
WO1992000112A1 (en) * | 1990-06-25 | 1992-01-09 | Ungerleider Bruce A | Apparatus for reducing intraocular pressure |
-
1993
- 1993-06-29 US US08/083,303 patent/US5322691A/en not_active Expired - Fee Related
- 1993-12-13 JP JP5311745A patent/JP2995137B2/en not_active Expired - Lifetime
-
1994
- 1994-05-17 US US08/243,915 patent/US5395618A/en not_active Expired - Fee Related
- 1994-06-20 CA CA002165071A patent/CA2165071C/en not_active Expired - Fee Related
- 1994-06-20 EP EP94923238A patent/EP0707464A4/en not_active Withdrawn
- 1994-06-20 WO PCT/US1994/007136 patent/WO1995001764A2/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3828777A (en) * | 1971-11-08 | 1974-08-13 | Alza Corp | Microporous ocular device |
US4730013A (en) * | 1981-10-08 | 1988-03-08 | Merck & Co., Inc. | Biosoluble ocular insert |
US5229128A (en) * | 1986-06-11 | 1993-07-20 | Haddad Heskel M | Drug delivery ophthalmic insert and method of preparing same |
Non-Patent Citations (1)
Title |
---|
See also references of EP0707464A4 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8691265B2 (en) | 2006-03-31 | 2014-04-08 | Mati Therapeutics, Inc. | Drug delivery methods, structures, and compositions for nasolacrimal system |
Also Published As
Publication number | Publication date |
---|---|
EP0707464A4 (en) | 1997-03-26 |
JP2995137B2 (en) | 1999-12-27 |
WO1995001764A2 (en) | 1995-01-19 |
US5395618A (en) | 1995-03-07 |
US5322691A (en) | 1994-06-21 |
CA2165071A1 (en) | 1995-01-19 |
EP0707464A1 (en) | 1996-04-24 |
CA2165071C (en) | 2000-08-15 |
JPH0767910A (en) | 1995-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1995001764A3 (en) | Ocular insert with anchoring protrusions | |
AU1159201A (en) | Ocular insert | |
US5425767A (en) | Anchor for an artificial ligament | |
EP1438938A3 (en) | Contraceptive system | |
CA2275921A1 (en) | Implant deployment apparatus | |
CA2015507A1 (en) | Spinal implant | |
DE69517838T2 (en) | Intrauterine contraceptive device | |
KR960033477A (en) | Occlusion insert and introduction cartridge | |
DE69925494D1 (en) | BALLOON CATHETER WITH BALLOON FILLING AT THE DISTAL BALLOONDE | |
WO1995001761A3 (en) | Internal graft prosthesis and delivery system | |
CA2233753A1 (en) | Drug delivery system for two or more active substances | |
EP1210919A3 (en) | Method of forming medical devices: intravascular occlusion devices | |
CA2139058A1 (en) | Controlled release drug formulation | |
CA2201342A1 (en) | Polymeric medical device systems having shape memory | |
CA2030459A1 (en) | Biodegradable ocular implants | |
GB2254002B (en) | Retrievable pessary | |
IE47381B1 (en) | Improvements in or relating to a support member for a prosthesis | |
EP0262893A3 (en) | Ocular insert | |
WO2000021396A3 (en) | Novel hair band system with storage and display device | |
US4497317A (en) | Vaginal device for contraceptive control | |
CA2176145A1 (en) | Biocompatible ocular implants | |
ES2085238A1 (en) | Ear-cleaning device | |
CA2010274A1 (en) | Biodegradable surgical implants and devices | |
UA5634A1 (en) | Device for drug introduction into the hollow organs | |
CA2512694A1 (en) | Flexible lifting apparatus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): CA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): CA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2165071 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1994923238 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1994923238 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1994923238 Country of ref document: EP |